Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001130319-06-000909
Filing Date
2006-11-03
Accepted
2006-11-03 15:01:26
Documents
4
Period of Report
2006-11-02

Document Format Files

Seq Description Document Type Size
1 FORM 6-K o33613e6vk.htm 6-K 242319
2 GRAPHIC o33613o3361303.gif GRAPHIC 3504
3 GRAPHIC o33613o3361300.gif GRAPHIC 11630
4 GRAPHIC o33613o3361301.gif GRAPHIC 1896
  Complete submission text file 0001130319-06-000909.txt   267658
Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-31062 | Film No.: 061186422
SIC: 2834 Pharmaceutical Preparations